Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
基本信息
- 批准号:7769934
- 负责人:
- 金额:$ 40.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAddressAdjuvantAmino AcidsAntibodiesAntigen PresentationAntigen ReceptorsAntigen-Presenting CellsAntigensAutoantigensAutoimmune DiseasesAutoimmunityBindingBiochemicalBiological ModelsBiologyBorrelia burgdorferiBrainCD1 AntigensCD4 Positive T LymphocytesCellsCellular ImmunityCeramidesComplexCrystallographyCytotoxic T-LymphocytesDataDevelopmentDiglyceridesDiseaseDockingEpitopesExperimental Autoimmune EncephalomyelitisFutureGalactosylceramidesGlycerolGlycolipidsGlycosphingolipidsGoalsHealthHelper-Inducer T-LymphocyteHexosesHost DefenseHumanHybridomasImmuneImmune responseImmune systemImmunologyInfectionInfectious AgentKineticsLightLinkLipidsLyme DiseaseLymphocyteMHC Class I GenesMeasuresModelingModificationMolecularMolecular StructureMultiple SclerosisMusMutagenesisOrder SpirochaetalesOrganismOutcomePeptidesPhospholipidsPlayProductionPropertyRecruitment ActivityRoentgen RaysRoleSeriesSideSpecificityStructureSulfoglycosphingolipidsSurface Plasmon ResonanceT-Cell ActivationT-Cell ReceptorT-LymphocyteTCR ActivationType II Epithelial Receptor CellVertebral columnantigen bindingbasecarbenecell typechemotherapeutic agentcombatcytokinefield studyinsightinterestkillingslipid structuremicrobialmicroorganism antigennovelpreferencepublic health relevanceresponsesugarthree dimensional structuretumorunsaturated bonds
项目摘要
DESCRIPTION (provided by applicant): Over the past 10 years, a tremendous amount of data has accumulated, which demonstrates the role of glycolipid-reactive T cells in autoimmune disease, host defense and tumor development. T cells and NKT cells can respond to a broad pool of self and foreign antigens presented by CD1 molecules and can trigger killing of the antigen presenting cell, through cytotoxic T lymphocytes (CTLs), or recruit help (T helper cells) from the humoral immune system through production of soluble antibodies. Our lab is interested in the molecular mechanisms of lipid antigen recognition in cell-mediated immunity. Toward this goal, we determine the binding kinetics of various glycolipid- reactive T cell receptor's (TCR's) with various CD1 antigen-presenting molecules by surface plasmon resonance studies (SPR). We will further correlate the obtained results with data obtained by measuring cytokine production upon T cell activation using T cell hybridomas. Ultimately we propose to determine the three-dimensional structure of CD1 antigen receptors in complex with different lipids and cognate T cell receptors (TCR's) by x-ray crystallography. We specifically address the following specific aims: 1) What are the biochemical and functional properties of human and mouse sulfatide-reactive NKT cells. We will determine the structure of sulfatide loaded human CD1a and mouse CD1d in complex with the respective TCR and characterize their binding kinetics by SPR. Comparisons of both complexes will provide insights into the similarities and disparities of sulfatide recognition by the immune system and will shed light on the molecular mechanism of their activation. 2) We will structurally and functionally characterize differences in glycolipid recognition of Borrelia burgdorferi glycolipids by human and mouse NKT cells. 3) We will characterize binding of novel endogenous self-lipids to mouse CD1d and their recognition by NKT cells. Structural insights into the differences of self vs. microbial antigen presentation will help understand the role of microbial lipids and lipid-reactive T cells in host defense and autoimmune diseases. Public Health Relevance: NKT cells are specialized lymphocytes that consist of several subtypes and can respond to glycolipids from infectious organisms, such as Borrelia burgdorferi the causative agent of Lyme disease and self-lipids, during the course of autoimmune disease such as Multiple sclerosis. Understanding the functional properties of these cell types at a molecular level is crucial for the future development of novel chemotherapeutic agents or adjuvants to combat both diseases.
描述(申请人提供):在过去的10年里,积累了大量的数据,证明了糖脂反应性T细胞在自身免疫性疾病、宿主防御和肿瘤发展中的作用。 T 细胞和 NKT 细胞可以对 CD1 分子呈递的大量自身和外来抗原作出反应,并可以通过细胞毒性 T 淋巴细胞 (CTL) 触发抗原呈递细胞的杀伤,或从体液免疫中招募帮助(T 辅助细胞)通过产生可溶性抗体的系统。我们的实验室对细胞介导的免疫中脂质抗原识别的分子机制感兴趣。为了实现这一目标,我们通过表面等离子共振研究 (SPR) 确定了各种糖脂反应性 T 细胞受体 (TCR) 与各种 CD1 抗原呈递分子的结合动力学。我们将进一步将获得的结果与使用 T 细胞杂交瘤测量 T 细胞激活时细胞因子产生所获得的数据相关联。最终,我们建议通过 X 射线晶体学确定 CD1 抗原受体与不同脂质和同源 T 细胞受体 (TCR) 复合物的三维结构。我们具体解决以下具体目标:1)人和小鼠脑硫苷脂反应性 NKT 细胞的生化和功能特性是什么。我们将确定载有硫苷脂的人 CD1a 和小鼠 CD1d 与各自 TCR 的复合物的结构,并通过 SPR 表征它们的结合动力学。两种复合物的比较将深入了解免疫系统识别脑硫苷脂的相似性和差异,并揭示其激活的分子机制。 2) 我们将从结构和功能上表征人类和小鼠 NKT 细胞对伯氏疏螺旋体糖脂识别的差异。 3) 我们将表征新型内源性自脂与小鼠 CD1d 的结合及其被 NKT 细胞的识别。对自身与微生物抗原呈递差异的结构了解将有助于了解微生物脂质和脂质反应性 T 细胞在宿主防御和自身免疫性疾病中的作用。公共健康相关性:NKT 细胞是一种特殊的淋巴细胞,由多种亚型组成,在多发性硬化症等自身免疫性疾病的过程中,可以对传染性生物体(例如莱姆病的病原体伯氏疏螺旋体)和自身脂质产生反应。在分子水平上了解这些细胞类型的功能特性对于未来开发对抗这两种疾病的新型化疗剂或佐剂至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dirk M Zajonc其他文献
Dirk M Zajonc的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dirk M Zajonc', 18)}}的其他基金
Design and evaluation of HLA-A, -B, and -C binding peptides that disrupt inhibitory KIR/MHC interaction and activate NK cells
设计和评估 HLA-A、-B 和 -C 结合肽,破坏抑制性 KIR/MHC 相互作用并激活 NK 细胞
- 批准号:
9227710 - 财政年份:2016
- 资助金额:
$ 40.76万 - 项目类别:
Structural basis of UL141 mediated NK cell inhibition by HCMV
HCMV 介导的 UL141 介导的 NK 细胞抑制的结构基础
- 批准号:
8873656 - 财政年份:2015
- 资助金额:
$ 40.76万 - 项目类别:
Structure and function of peptide presentation by CD1d
CD1d 肽呈递的结构和功能
- 批准号:
8569883 - 财政年份:2013
- 资助金额:
$ 40.76万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
8362144 - 财政年份:2011
- 资助金额:
$ 40.76万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
8170083 - 财政年份:2010
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8427352 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8214630 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
7954410 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8019102 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
7655604 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The role of natural killer T cells in the innate response to lung infection
自然杀伤 T 细胞在肺部感染先天反应中的作用
- 批准号:
8632820 - 财政年份:2014
- 资助金额:
$ 40.76万 - 项目类别:
The role of natural killer T cells in the innate response to lung infection
自然杀伤 T 细胞在肺部感染先天反应中的作用
- 批准号:
8862370 - 财政年份:2014
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8427352 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8214630 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8019102 - 财政年份:2009
- 资助金额:
$ 40.76万 - 项目类别: